info@biomedres.us   +1 (720) 414-3554
  One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA

Biomedical Journal of Scientific & Technical Research

April, 2019, Volume 17, 2, pp 12611-12617

Research Article

Research Article

Immunochemical Characterization of Licorice Root Proteins and Assessment of Their Effects on Proliferation of Cancer Cells

Girum Tefera Belachew1,2, Mir Hadi Seyedzadeh2, Masoud Javanmardi3, Kobra Mokhtarian4, Reza Falak5, Zahra Pourpak2, Mohammad Ali Mazlomi1 and Gholam Ali Kardar1,2*

Author Affiliations

1Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran,Iran

2Immunology, Asthma & Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran

3Department of Medical Biotechnology, Science and Research Branch, Islamic Azad University, Tehran, Iran

4Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran

5Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran

Received: April 10, 2019 | Published: April 18, 2019

Corresponding author: Gholam Ali Kardar, Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Immunology, Asthma & Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran

DOI: 10.26717/BJSTR.2019.17.002964

Abstract

Background

Root of licorice (Glycyrrhiza glabra) is traditionally applied in herbal medicine. In this study, we aimed to fractionate licorice root proteins and investigate their inhibitory effects on proliferation and development of gastrointestinal cancer cells.

Methods

Licorice root powder was solubilized in potassium phosphate buffer and the electrochemically resolved proteins were characterized by mass spectrometry. The antiproliferative activity of the fractionated proteins was determined by MTT assay. Moreover, we determined their capacity for induction of programmed cell death in cancer cells and peripheral blood mononuclear cells by flow cytometry.

Results

Three proteins including beta-amylase-like isoform X1 (67kDa), chitinase A (30kDa), and dirigent protein 21-like (20kDa) were characterized by mass spectrometry. We found that 2μg/ml concentration of 20kDa and 67kDa proteins only showed anti-proliferative effects on cancerous cells (P<0.05), but none of them influenced normal cells. Meanwhile, at similar concentrations the purified 30kDa protein inhibited proliferation of both cancerous and normal cells.

Conclusion

In this study, three major proteins of licorice root were characterized. Our findings suggest that a couple of these fractions can hinder the growth of cancer cell lines without showing any adverse effects on normal cells. Obviously, the recombinant protein technology may help us to determine the molecular mechanisms and functionality of these proteins.

Keywords: Apoptosis; Cancer cell lines; Licorice; Identification

Introduction

Cancer is a serious pathological state and is regarded as the first line causative mechanism of death in developed nations and also as the second primary agent of mortality in developing countries [1,2]. Epidemiological studies show that increasing the life expectancy in patients with end stage cancers is almost impossible at the present time, even though, great promotion was achieved in treatment regimens [3]. On the other hand, Ethno medicinal herbs, such as Licorice (Glycyrrhiza glabra), as low-cost plant medicinal therapeutics could be used to prevent or aid in healing of low-grade cancers. Licorice can even be regarded as an operative botanical dietary for chemoprevention. An improving number of evidences confirm that licorice exhibits anti-carcinogenic properties. The root of licorice has been one of promising medicinal plants and were globally applied as natural medication, thus could be pointed out as ‘The grandfather of herbs’ [3]. It grows naturally in China, Japan, Russia, Iran, Spain, and India [4]. It was shown that Licochalcone A isolated from licorice showed in vitro inhibitory activity in HeLa cells [5], and induced apoptosis in human cervical cancer cells [6] and can prevent skin tumor initiation in mice [7].

One of the active components of Licorice, 18β-Glycyrrhetinic acid, suppresses cell proliferation through inhibiting thromboxane synthase in non-small cell lung cancer [8]. Furthermore, oral administration of 1.0% aqueous solution of licorice to female A/J mice in drinking water caused significant inhibition of tumor incidence [9]. The medicinal outcome of licorice, involving antiinflammatory, antiviral, and hepato-protective results, was demonstrated previously. Recently anti-cancer features of several chemical components of licorice, with proteinous or flavonoids structures were approved both in vitro and in vivo [10-12]. Evaluation of the apoptotic effects of licorice extract and its derivatives on a number of cancer cells were encouraging [13]. Studies on rats showed that some components of licorice could reverse PI3K, MMK4, MMK7, JNK1, mTOR, and Cdk2 functionalities by minimizing carcinogenesis [14]. Recently, it was shown that some protein fractions and total extract of licorice root can significantly prevent the proliferation of a couple of colon cancer cell lines (HT 29 and CT 26) and induce apoptosis [10]. Hemo-preventive approach using non-toxic botanicals is a novel therapeutic strategy for cancer management which may reduce morbidity and mortality of the patients or at least increase their life quality. In this study, we investigated the growth inhibitory effects of the protein fractions of licorice root extract on cancer cell lines.

Materials and Methods

Materials

Powder of Licorice root extract was prepared as previously described (REF). The reagents and chemicals were purchased from Sigma-Aldrich, Orange, Invitrogen, or Nunc companies. Buffers used for fast protein liquid chromatography analysis were of analytical grade. Gastrointestinal cancer cell lines including AGS, KYSE-30, and HCT-116, were purchased from National Cell Bank of Iran (Pasture Institute, Tehran, Iran) and aseptically propagated in RPMI 1640 medium (Invitrogen, USA), supplemented with 10% fetal bovine serum (Invitrogen, USA), 1X penicillin/streptomycin (Invitrogen, USA), and then the culture flasks were kept in a humidified CO2 incubator in standard conditions.

Extract Preparation

To prepare a standard protein extract, 1g of the fine powder of licorice root extract was mixed in phosphate buffered saline (PBS) pH 7.0 and stirred for 48 h at 4°C, on an orbital shaker at 800 rpm [10]. Then the homogenate was clarified by centrifugation at 13000 x g for 10 minutes and the clear supernatant was collected as raw extract. The pigments were removed by dialysis against PBS, overnight and the protein concentration of the extract was determined by Bradford method.

Protein Fractionation by FPLC

Licorice protein extract was fractionated by ion exchange chromatography using fast protein liquid chromatography (FPLC) system. In briefly, GE Healthcare Biosciences, AKTA Prim Plus FPLC system equipped with a CL-6B DEAE-Sepharose 6B column (Sigma Aldrich, USA) was used for fractionation of the extract. First of all, the column washed and equilibrated with starting buffer (20mM Tris-HCl pH 8.0), then the dialyzed extract loaded onto the column following filtration through a 0.45μm filter. When the optical density of the elutes in 280 nm reached to the baseline, an increasing gradient of NaCl (prepared in the starting buffer) was added and the flow rate was adjusted to 1ml/min and typical peaks were isolated. The purity and protein contents of the peaks were checked by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE).

SDS-PAGE and Electro-Elution

Fractionated proteins were further resolved on 10% SDS-PAGE. Following colloidal Coomassie blue staining the desired protein bands were cut and removed from the gel and after destining were subjected to mass spectrometry analysis [10].

Protein Characterization by Mass Spectrometry

Following in gel digestion, Mass spectrometry analysis was performed using an ABI 4800 MALDI TOF/TOF analyzer (Applied Biosystems, Foster City, CA, USA). Mass spectra were recorded in reflector positive mode with a scanning range of 900-4000 Da. Five monoisotopic precursors from each purified fraction with signal/noise (S/N) ratios greater than 200 were selected for mass spectrometry (MS/MS). Peptide mass fingerprinting (PMF) of the target proteins were determined by searching MASCOT database and employing Biotools software (Bruker Daltonik GMBH, Germany).

Cytotoxicity Assay

The anticancer activity of the fractionated proteins was determined by MTT dye assay (Sigma- Aldrich, Germany). The cancer cell lines and peripheral blood mononuclear cells (PBMC) were seeded in triplicate in 96 well plates with cell densities of 5x103 and 5x104 cells/well in 200μl volume, respectively. Following an overnight incubation, cells were treated with each of protein fractions in different concentrations (2,5, and 10μg/ml). Then 20μl of MTT stock solution (5mg/ml) was added to each well and incubated for 4h. Afterward, 100μl of DMSO was added to each well and the plates incubated for further 15 minutes on a shaker. Finally, the absorbance was measured at 570 nm using microplate reader (Bio-TEK, USA).

Apoptosis Assay

To determine cytotoxic effects of the fractions, cancer cell lines as well as PBMC were seeded with cell densities of 4x104 and 1.5 x105 cells/well in 24-well culture plate in 1ml volumes, respectively and the cells were treated as described above and incubated overnight in standard conditions. For detection of apoptosis, cells were stained simultaneously with FITC-conjugated Annexin V and propidium iodide (PI; Invitrogen, USA) according to the manufacturer’s instructions. Total numbers of apoptotic cells were determined by calculation of Annexin V+ and PI- cells (Q3, as early apoptosis events) together with Annexin V+ and PI+ (Q2, as late apoptosis events) cells.

Statistical Analysis

All experiments were performed in triplicate. Data from cell viability and flow cytometry analysis were illustrated as mean ± standard deviation (SD). SPSS version 24 (IBM) were used for statistical analysis and Graph Pad Prism software (Version 6) was used to draw the plots. Student’s t-test used for comparison of the difference between the results and finally, difference with P value less than 0.05 regarded as statistically significant.

Results

Identification and Characterization of Licorice Proteins by Mass Spectrometry

The peptide mass fingerprinting (PMF) of the SDS-PAGE resolved proteins (Figure 1) were obtained by MALDI-TOF-MS. The spectrum was emitted from in-gel trypsin digestion. The spectra of five protein fractions were searched against the NCBInr database using MASCOT. We restricted the quest to Viridiplantae (4046923 sequences) which finally yielded just three matches. In brief, beta-amylase-like isoform X1(67kDa), chitinase A(30kDa), and dirigent protein 21-like (20kDa) were detected. During the protein identification and characterization procedure for our 5 protein fractions, the spectra were searched against the NCBInr database restricted to Viridiplantae (4046923 sequences) and yielded just three matches. The detected peptides matched to dirigent protein 21-like, a protein which is found in the plant is known as Arachis duranensis, beta-amylase-like isoform X1, a protein which is found in Cucumis melon plant and chitinase A which is also found in the plant called Ananas comosus, respectively (Table 1). But we did not get any significant matches from the other two fractions, (fraction 3 and 4) by MASCOT Search engine in the NCBInr database.

Figure 1: Separated protein fractions from licorice root extract by 12% SDS-PAGE polyacrylamide gel electrophoresis. M; molecular weight marker.

Table 1: The three characterized protein fractions result from MALDI-TOF-Ms and MASCOT Search engine in the NCBInr database.

Anti-Proliferative Effects of The Licorice Protein Fractions

The MTT assay demonstrated that 2-5μg/ml concentrations of beta amylase-like isoform X1 (67kDa) have a significant antiproliferative effect on AGS and KYSE-30 (P<0.05) cells, without any adverse effects on normal PBMC (P > 0.05). Furthermore, 2μg/ml of dirigent protein 21-like (20kDa) showed a significant inhibitory effect on each of the studied cancer cell lines (P<0.05). While, Chitinase A (30kDa) showed anti-proliferative effects on both cancerous cells and normal PBMCs (P<0.05). Statistically, at 2μg/ml the anti-proliferative effect of dirigent protein 21-like was more significant on cancerous cells than other simultaneously characterized proteins. Treatment with 2μg/ml of dirigent protein 21-like proved that the viability of the cancerous cells was considerably less than control PBMC and they were more prone to apoptosis (Figure 2).

Figure 2: Effects of the three characterized protein fractions on the viability of the AGS, KYSE-30, HCT-116 cells in vitro. Cells were treated with 2μg/ml for 24 hr.

Licorice Proteins Induce Stimulated Apoptosis of Cancer Cells

After proving that fraction containing 30, 20 and 67kDa proteins were capable to decrease the viability of cancerous cells; we checked their effect on stimulated apoptosis. To achieve this, the cells were incubated for 24h with the same concentration (2μg/ml) of the aforementioned protein fractions. Purified dirigent protein 21-like, beta-amylase- X1 like isoform and chitinase A were capable to induce apoptosis in the target cancer cell lines (Figure 3). Table 2 showed the comparison of the mean ± standard deviation and p-values of the treated (2μg/ml) and the untreated cancer cell lines and PBMCs in induction of apoptosis. As shown in Figure 4, very similar to the results of anti-proliferative assay, only 30 KDa protein induced apoptosis in normal PBMC cells (Figure 4).

Table 2: Comparison of the mean μ standard deviation and p-values of the treated (2g/ml) and the untreated cancer cell lines and PBMCs in apoptosis assay.

Figure 3: The three characterized protein fractions from licorice root extract induced apoptosis in gastro intestinal cancer cell lines. Cells were treated with 2μg/ml for 24hr.

Figure 4: Effects of fractions on PBMC apoptosis. Based to results, just 30 KDa fraction was induced apoptosis in PBMC normal cells.

Discussion

Since gastrointestinal cancer is seriously affecting a large number of people annually, introducing consumable plant sources and advocating a novel anti-cancer treatment might be helpful. In spite of an up-to-date improvement in control of carcinogens agents, the growing frequency and comparatively poor efficacy of chemotherapy have pushed the researchers for development of unique and promising methods. The majority of chemically cytotoxic medications which are commonly applied for cancer treatment have considerable adverse effects. So, it is ideal to look for development of innovative formulations from natural plant sources with significance functionality and minimal side effects [15]. Licorice is a well-known herbal medicine with considerable anti-inflammatory, anti-microbial, anti-fungal, antiviral and anticancer activities [16].

A number of herbal medicinal compounds have been assessed as anti-cancer agents versus HCT 116, esophageal and AGS cancer cells. Alsheri et al. [17] shown that Cichorium endivia L. phenolic extracts which involve a mixture of phenolic compounds have antiproliferative property on HCT-116 cancer cells. Bandopadhyaya et al. [18] have demonstrated that methanolic extracts of C. camphora, C. roseus and E. officinalison shows anti-proliferative activity on human colorectal cancer cells (HCT116) [18]. Sheng Li et al. [19] also showed that Crocetin applies a significant chemo-preventive upshot towards esophageal cancer via stopping cell proliferation, dissemination, and initiation of apoptosis [19]. In another study, Faried et al. [20] confirmed that the Gallic acid obtained from Indonesian medicinal plant, Phaleria macrocarpa, has antitumor outcomes on TE-2 as human esophageal cancer cells [20]. Heidari et al. [21] have reported Ferulago angulata Boiss extract has the anti-proliferative role and induces apoptosis on gastric cancer cell line (AGS) [21]. Kim et al. [22] also shown that ethanol extract of Rhus verniciflua Stokes brought on a dose-dependent reduction in the cell viability (IC50: 50μg/mL) and activated apoptosis through the intrinsic apoptosis pathway in human gastric cancer cells [22].

In another research, a couple of ingredients isolated from licorice named glycyrrhetinic acid and glycyrrhizic acid could increase death of cancer cells, following 24 and 48 hours of incubation and initiate apoptosis and cell cycle arrest in G1 phase. This might be because of an elevation in the PARP (Poly ADPribose polymerase) and caspase-3 expression and the reduction of Bcl-xl, BCL2, cyclin D1 and cyclin E expression [23]. Khazraei- Moradian et al. [10] also showed that the licorice protein fractions brought the growth inhibition effect and induction of apoptosis in gastrointestinal cancer cell lines such as CT 26 and HT 29 [10]. Various non-protein licorice compounds most certainly revealed to acquire a good number of valuable activities which can include antioxidant [24], and antitumor [25] capabilities. The final result of non-protein licorice constituents on combating cancer was already explored quite a lot [26] and well indicated that it could cut back tumor growth and increase the lifelong of cancer victim mice [27].

Quite a lot of researchers have proven that non-protein ingredients obtained from the licorice root such as flavonoid, and polysaccharides have the ability to induce apoptosis in cancer cells, consequently being able to reverse the growth of cancer cells [28]. Aside from that, a number of investigations revealed that licorice and its bioactive constituents restrain cancer cell growth through induction of apoptosis, cell cycle arrest, and autophagy [29,30]. In brief, in this research, we characterized three proteins from the licorice root. A couple of them namely; dirigent protein 21-like and beta amylase-like isoform X1 showed a significant anti-proliferative effect and could induce apoptosis on the aforementioned cancerous cells with non-significant side effects on the normal cells at lower concentrations (up to 2μg/ml). This result was in consistency with our previous findings [10].

Conclusion

Our findings revealed that some protein fractions of licorice root extract could block proliferation of gastrointestinal cancer cells and induce their apoptosis. Furthermore, the application of FPLC together with sequencing data from MALDI-TOF mass spectrometry (MS) may open a new horizon for production pf recombinant forms of the characterized proteins for future studies.

Acknowledgement

This study was financially supported by The International Campus of Tehran University of Medical Sciences (Grant # 32518). We would like to convey our gratitude to Immunology, Asthma & Allergy Research Institute personnel.

References

Research Article

Immunochemical Characterization of Licorice Root Proteins and Assessment of Their Effects on Proliferation of Cancer Cells

Girum Tefera Belachew1,2, Mir Hadi Seyedzadeh2, Masoud Javanmardi3, Kobra Mokhtarian4, Reza Falak5, Zahra Pourpak2, Mohammad Ali Mazlomi1 and Gholam Ali Kardar1,2*

Author Affiliations

1Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran,Iran

2Immunology, Asthma & Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran

3Department of Medical Biotechnology, Science and Research Branch, Islamic Azad University, Tehran, Iran

4Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran

5Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran

Received: April 10, 2019 | Published: April 18, 2019

Corresponding author: Gholam Ali Kardar, Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Immunology, Asthma & Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran

DOI: 10.26717/BJSTR.2019.17.002964

Abstract

Background

Root of licorice (Glycyrrhiza glabra) is traditionally applied in herbal medicine. In this study, we aimed to fractionate licorice root proteins and investigate their inhibitory effects on proliferation and development of gastrointestinal cancer cells.

Methods

Licorice root powder was solubilized in potassium phosphate buffer and the electrochemically resolved proteins were characterized by mass spectrometry. The antiproliferative activity of the fractionated proteins was determined by MTT assay. Moreover, we determined their capacity for induction of programmed cell death in cancer cells and peripheral blood mononuclear cells by flow cytometry.

Results

Three proteins including beta-amylase-like isoform X1 (67kDa), chitinase A (30kDa), and dirigent protein 21-like (20kDa) were characterized by mass spectrometry. We found that 2μg/ml concentration of 20kDa and 67kDa proteins only showed anti-proliferative effects on cancerous cells (P<0.05), but none of them influenced normal cells. Meanwhile, at similar concentrations the purified 30kDa protein inhibited proliferation of both cancerous and normal cells.

Conclusion

In this study, three major proteins of licorice root were characterized. Our findings suggest that a couple of these fractions can hinder the growth of cancer cell lines without showing any adverse effects on normal cells. Obviously, the recombinant protein technology may help us to determine the molecular mechanisms and functionality of these proteins.

Keywords: Apoptosis; Cancer cell lines; Licorice; Identification